NeoGe­nomics spends $125M to ex­pand ops; Cara hires Cel­gene ex­ec as CMO

→ Can­cer-fo­cused ge­net­ic test mak­er NeoGe­nomics $NEO said it would ac­quire to ac­quire Genop­tix, an on­col­o­gy lab­o­ra­to­ry that spe­cial­izes in hema­tol­ogy and sol­id tu­mor test­ing …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER